Stay informed with the latest litigation news. Explore now

IP Verse

Purification Of Recombinantly Produced Polypeptides - EP2997036B1

EP2997036

MEDIMMUNE
Application Number
EP14797310A
Filing Date
May 13, 2014
Status
Granted And Under Opposition
Jan 29, 2021
Grant Date
Mar 3, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3218406B2
EP3157629B1
EP1942939B2

Bibliography

The patent EP2997036B1 was granted to Medimmune on Mar 3, 2021 following the initial filing on May 13, 2014 under the application number EP14797310A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GLAXOSMITHKLINEDec 3, 2021ADMISSIBLE
OETKEDec 3, 2021ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents